Laporan Laba Rugi (TTM)
Laporan Laba Rugi Eastwood Bio-Medical Canada Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 10-31 |
2021 01-31 |
2021 04-30 |
2021 07-31 |
2021 10-31 |
2022 01-31 |
2022 04-30 |
2022 07-31 |
2022 10-31 |
2023 01-31 |
2023 04-30 |
2023 07-31 |
2023 10-31 |
2024 01-31 |
2024 04-30 |
2024 07-31 |
2024 10-31 |
2025 01-31 |
2025 04-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Change (%) | 8.70 | 11.81 | 4.63 | 7.41 | 13.43 | 1.50 | 5.31 | 9.27 | 0.09 | -6.38 | -8.06 | -22.49 | -15.11 | -11.46 | 0.19 | 7.43 | 1.95 | -8.16 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change (%) | 7.87 | 6.44 | 1.81 | -17.01 | -8.21 | -21.04 | -17.13 | 26.46 | 2.42 | 2.90 | -2.68 | -21.52 | -7.79 | -14.96 | -1.64 | 0.48 | -2.07 | -3.87 | |
% of Revenue | 75.00 | 74.44 | 70.86 | 68.95 | 53.28 | 43.11 | 33.54 | 26.39 | 30.55 | 31.26 | 34.35 | 36.37 | 36.82 | 40.00 | 38.42 | 37.72 | 35.28 | 33.89 | 35.47 |
Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Change (%) | 11.16 | 27.45 | 11.48 | 61.61 | 38.11 | 18.59 | 16.64 | 3.10 | -0.93 | -10.59 | -10.88 | -23.04 | -19.39 | -9.13 | 1.33 | 11.63 | 4.15 | -10.36 | |
% of Revenue | 25.00 | 25.56 | 29.14 | 31.05 | 46.72 | 56.89 | 66.46 | 73.61 | 69.45 | 68.74 | 65.65 | 63.63 | 63.18 | 60.00 | 61.58 | 62.28 | 64.72 | 66.11 | 64.53 |
SG&A | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Change (%) | -2.53 | -0.66 | 14.78 | -19.42 | -2.09 | -3.26 | -0.51 | 4.38 | 5.86 | 1.52 | -2.06 | -4.45 | -11.95 | -9.42 | -1.35 | 1.31 | -3.37 | 0.64 | |
% of Revenue | 143.43 | 128.62 | 114.27 | 125.36 | 94.06 | 81.19 | 77.38 | 73.10 | 69.83 | 73.86 | 80.08 | 85.31 | 105.17 | 109.09 | 111.62 | 109.90 | 103.64 | 98.24 | 107.65 |
R&D | |||||||||||||||||||
Change (%) | |||||||||||||||||||
% of Revenue | |||||||||||||||||||
OpEx | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Change (%) | 0.97 | 1.81 | 9.20 | -17.52 | -3.98 | -8.72 | -5.07 | 9.40 | 4.47 | 1.80 | -2.07 | -8.83 | -10.02 | -9.96 | -1.31 | 1.05 | -1.04 | -2.94 | |
% of Revenue | 233.15 | 216.57 | 197.20 | 205.83 | 158.07 | 133.80 | 120.32 | 108.46 | 108.60 | 113.34 | 123.25 | 131.29 | 154.42 | 163.69 | 166.47 | 163.97 | 154.24 | 149.71 | 158.21 |
Operating Income | -1 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
Change (%) | -4.84 | -6.77 | 13.91 | -41.07 | -33.97 | -38.98 | -56.15 | 11.02 | 55.35 | 63.12 | 23.72 | 34.82 | -0.65 | -7.60 | -3.58 | -8.91 | -6.57 | 7.55 | |
% of Revenue | -133.15 | -116.57 | -97.20 | -105.83 | -58.07 | -33.80 | -20.32 | -8.46 | -8.60 | -13.34 | -23.25 | -31.29 | -54.42 | -63.69 | -66.47 | -63.97 | -54.24 | -49.71 | -58.21 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |
Change (%) | 144.03 | 4.58 | 20.85 | -0.00 | -0.00 | -0.00 | 283.97 | -0.00 | 2.79 | 0.05 | 155.83 | -0.00 | -0.00 | -0.00 | -77.68 | 2.82 | 0.39 | ||
% of Revenue | -0.12 | -0.25 | -0.25 | -0.28 | -0.25 | -0.25 | -0.23 | -0.82 | -0.82 | -0.90 | -0.98 | -3.24 | -3.82 | -4.32 | -4.31 | -0.90 | -0.90 | -0.99 | |
Net Income | -1 | -1 | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -0 | -0 | -0 | -0 | -0 |
Change (%) | -6.14 | -3.55 | 13.32 | -30.98 | -30.02 | -47.64 | -41.08 | 15.03 | 39.30 | 70.20 | 9.00 | 41.12 | -2.74 | -8.60 | -0.35 | -5.84 | -2.86 | 6.05 | |
% of Revenue | -118.67 | -102.47 | -88.39 | -95.74 | -61.53 | -37.96 | -19.58 | -10.95 | -11.53 | -16.05 | -29.17 | -34.59 | -62.98 | -72.16 | -74.49 | -74.08 | -64.93 | -61.86 | -71.44 |
Source: Capital IQ